Dashboard
Faculty
Programme
Login
Dashboard
Faculty
Programme
Login
VCA: Cutting Edge Advances and Applications
Tuesday September 15, 2020 from 11:15 to 13:00
Room: Channel 4
393.1 Calcineurin-free immunosuppression in VCA – Outcomes and opportunities
Log in to add to favorites
Add Personal Notes
Linda C. Cendales, United States
Director, Duke Vascularized Composite Allotransplantation Program
Chair, Diversity and Inclusion Committee
Duke University, School of Medicine
Presentations by Linda C. Cendales
Tue-15 from 11:15 - 13:00 in room Channel 4
VCA: Cutting Edge Advances and Applications
Calcineurin-free immunosuppression in VCA – Outcomes and opportunities
Email:
info@virtual.tts.org
+1.514.874-1717
© 2024 TTS 2020
